Complix NV
Latest round
- Series B
Last raised
- Jun 2013
Total raised
- $27M
Investors
- 10
About Complix NV
Founded in 2008 and based in Belgium, Complix NV operates as a biopharmaceutical company that focuses on developing Alphabody-based therapeutics for the treatment of oncology and autoimmune diseases.
Who invested in Complix NV
10 investors across 4 rounds
See all investors in Complix NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Complix NV
Who invested in Complix NV?
Complix NV has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Complix NV raised?
Complix NV has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Complix NV last raise money?
Complix NV's most recent round on record is a Series B, in Jun 2013.
What does Complix NV do?
Founded in 2008 and based in Belgium, Complix NV operates as a biopharmaceutical company that focuses on developing Alphabody-based therapeutics for the treatment of oncology and autoimmune diseases.
Where is Complix NV headquartered?
Complix NV is headquartered in Belgium.
Which VCs invest in companies like Complix NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Complix NV's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Complix NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.